Research and Clinical Trials

DART NeuroScience, LLC
Brief Description  
Randomized, double-blind, placebo-controlled parallel group outpatient study that utilizes standard stroke rehabilitation outcome measures, as well as fMRI tecniques to evaluate the effect of study drug, monoamine oxidase Type B (MAO-B) inhibitor, HT-3951, on motor recovery and behavior in medically stable subjects following ischemic stroke.
Who may be Eligible  
Medically and neurologically stable male and female subjects 40-85 years of age. Subjects with mild to moderate, unilateral upper extremity motor impairment with =2 and =6 weeks post stroke acute subjects, and between >6 and =24 weeks post-stroke chronic subjects, and will initiate, or are scheduled to undergo, simultaneous standardized upper limb rehabilitation under the supervision of a licensed therapist at least 2 weeks before Day 1.
Start Date  
IRB Number  
Principal Investigator  
Nguyen, Vu
Contact Name  

For More Information, Contact  Marybeth  P, Whitney
Phone:  (704) 355-1409  Fax:  (704) 355-3676  
Address:1100 Blythe Blvd. Charlotte, NC 28203